Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03721393 · ClinicalTrials.gov registry record

Data Collection - Of Syncope Tilt Table Testing Study

A clinical trial of Orthostatic Hypotension and Reflex Syncope, sponsored by Boston Scientific Corporation.

Completed
Registry status
50
Enrollment target
1
Study location

NCT03721393 is a study of Orthostatic Hypotension and Reflex Syncope that has completed, run by Boston Scientific Corporation. The registered enrollment target is 50 participants, roughly in line with the 49-participant average among 16 other Orthostatic Hypotension trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03721393, a study of Orthostatic Hypotension and Reflex Syncope, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

To characterize the impact of orthostatic hypotension (OH) and reflex syncope on signals measured using a wearable cardiac monitor prototype device. To evaluate the relationship of signals measured from the wearable cardiac monitor prototype device with reported symptom severity of orthostatic intolerance per standard data collection, analysis, and questionnaires.

Interventions

  • DEVICE Wearable heart monitor

Study Locations (1)

Minnesota

  • Mayo Clinic Foundation - Rochester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-10-04
Est. Completion 2023-05-08

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT03721393

The ClinicalTrials.gov registry entry for NCT03721393 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 49-participant average among 16 other Orthostatic Hypotension trials with a reported enrollment target. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Orthostatic Hypotension appearing as the primary indexed condition, and to 1 intervention - of which Wearable heart monitor is the first listed.

NCT03721393 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03721393 about?

NCT03721393 is a clinical study titled "Data Collection - Of Syncope Tilt Table Testing Study". To characterize the impact of orthostatic hypotension (OH) and reflex syncope on signals measured using a wearable cardiac monitor prototype device. To evaluate the relationship of signals measured from the wearable cardiac monitor prototype device with reported symptom severity of orthostatic into...

What is the current status of trial NCT03721393?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2019-10-04. Estimated completion is 2023-05-08.

What conditions does trial NCT03721393 study?

This clinical trial studies the following conditions: Orthostatic Hypotension, Reflex Syncope.

What interventions are being tested in trial NCT03721393?

The interventions under investigation include: Wearable heart monitor (DEVICE).

Who is sponsoring clinical trial NCT03721393?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03721393 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Orthostatic Hypotension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.